https://doi.org/10.4081/ejh.2020.3166
LncRNA GClnc1 may contribute to the progression of ovarian cancer by regulating p53 signaling pathway
Accepted: 4 September 2020
HTML: 7
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Ovarian cancer (OC) is one of the most prevalent and deadly types of gynecological malignancy. Since current treatments are not effective against OC, it is imperative to develop novel potential therapeutic targets for managing OC. In this study, we aimed to uncover the underlying molecular mechanism of long non-coding RNA (lncRNA) GClnc1 related to p53 signaling pathway in OC. The expression of lncRNA H19 GClnc1 was markedly higher in OC samples than the related normal tissues. Next, we found that lncRNA GClnc1 inhibited p53. In addition, the lncRNA GClnc1 overexpression promoted the cell proliferation and migration in vitro. Subsequently, p53 silencing obligated the effect of lncRNA GCln1 knock down on cell proliferation and migration. To sum up, LncRNA GClnc1 contributes to the progression of OC by regulating p53 signaling pathway. Meanwhile, our findings also suggested that lncRNA GClnc1 may serve as a novel therapeutic target for OC patients.
How to Cite
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Jianyu Zou, Zhenbin Cai, Zhi Liang , Yaozhong Liang, Guowei Zhang, Jie Yang, Yunlong Zhang, Hongsheng Lin, Minghui Tan, Different fusion tags affect the activity of ubiquitin overexpression on spastin protein stability , European Journal of Histochemistry: Vol. 65 No. 4 (2021)
- V. Giansanti, G. Santamaria, A. Torriglia, F. Aredia, A.I. Scovassi, G. Bottiroli, A.C. Croce, Fluorescence properties of the Na+/H+exchanger inhibitor HMA (5-(N,N-hexamethylene)amiloride) are modulated by intracellular pH , European Journal of Histochemistry: Vol. 56 No. 1 (2012)
- Anett Kristin Larsen, Jaione Simón-Santamaría, Kjetil Elvevold, Bo Göran Ericzon, Kim Erlend Mortensen, Peter McCourt, Bård Smedsrød, Karen Kristine Sørensen, Autofluorescence in freshly isolated adult human liver sinusoidal cells , European Journal of Histochemistry: Vol. 65 No. 4 (2021)
- Carlo Alberto Redi, RNA therapeutics - Function, design and delivery , European Journal of Histochemistry: Vol. 55 No. 2 (2011)
- C. Pellicciari, On the future contents of a small journal of histochemistry , European Journal of Histochemistry: Vol. 56 No. 4 (2012)
- D.G.B. Araújo, L. Nakao, P. Gozzo, C.D.A. Souza, V. Balderrama, E.S. Gugelmin, A.P. Kuczynski, M. Olandoski, L. de Noronha, Expression level of quiescin sulfhydryl oxidase 1 (QSOX1) in neuroblastomas , European Journal of Histochemistry: Vol. 58 No. 1 (2014)
- Yan Yan Li, Ya Ping Feng, Li Liu, Jin Ke, Xing Long, Inhibition of HMGB1 suppresses inflammation and catabolism in temporomandibular joint osteoarthritis via NF-κB signaling pathway , European Journal of Histochemistry: Vol. 66 No. 3 (2022)
- F Cappello, A Ribbene, C Campanella, AM Czarnecka, R Anzalone, F Bucchieri, The value of immunohistochemical research on PCNA, p53 and heat shock proteins in prostate cancer management: a review , European Journal of Histochemistry: Vol. 50 No. 1 (2006)
- Massimo Allegri, Analgesia - Methods and Protocols , European Journal of Histochemistry: Vol. 55 No. 1 (2011)
- D Waltregny, B North, F Van Mellaert, J de Leval, E Verdin, V Castronovo, Screening of histone deacetylases (HDAC) expression in human prostate cancer reveals distinct class I HDAC profiles between epithelial and stromal cells , European Journal of Histochemistry: Vol. 48 No. 3 (2004)
<< < 20 21 22 23 24 25 26 27 28 29 > >>
You may also start an advanced similarity search for this article.
